Recruiting

MiWeigh

Sponsor:

University of Michigan

Code:

NCT07465341

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

MiWeigh

Enhanced Usual Care (EUC)

Study Details

Brief summary:

The main purpose of this study is to determine whether people who participate in MiWeigh lose more weight than people who receive information about weight loss strategies and programs. The researchers also want to learn what parts of the program do and do not work and why. If the program is effective, the researchers want to learn how other health care systems could offer this program.

The overarching aim of the MiWeigh Study is to better help patients prevent, manage, or reverse obesity-related chronic conditions.

Conditions

Obesity

Study ID

NCT07465341

Start date

Apr 9, 2026

Status verified date

Jun, 2026

Completion date

Sep 30, 2028

Anticipated

Primary completion date

Sep, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Body Mass index (BMI) 30 kilogram per square meter or higher
  • Diagnosed with one or more of the following weight-related conditions:

  • Type 2 Diabetes
  • Prediabetes Mellitus
  • Hyperlipidemia (HLP)
  • Hypertension (HTN)
  • Polycystic Ovary Syndrome (PCOS)
  • Obstructive Sleep Apnea (OSA) and/or
  • Metabolic dysfunction-associated steatotic liver disease (MASLD)
  • Speaks English
  • Interest in losing weight
  • Willingness to complete assessments per study protocol
  • Willing and able to use the Electronic health records patient portal to respond to messages
  • Willing to report weight weekly by text if randomized to intervention arm
  • Able to see provider virtually at certain days/times up to four times in a year

Exclusion Criteria:

  • ≥ 5% weight loss within the prior 12 months
  • Has had a Weight Navigation Program visit in past
  • Pregnant, planning a pregnancy, or breastfeeding in the next year
  • Ongoing participation in another weight-loss program
  • Taking an anti-obesity medication
  • Ever diagnosed with Type 1 Diabetes Mellitus (per protocol)
  • Dementia
  • Serious uncontrolled mental health conditions as indicated (per protocol)
  • Chronic kidney disease, Stage 4 or higher
  • Alcohol dependence and opioid dependence (per protocol)
  • History of anorexia or bulimia
  • Bariatric/ gastric bypass surgery, gastric sleeve surgery, or gastric balloon procedure in last year
  • Currently enrolled in an interventional research study that is examining how a diet, program, or drug might: promote physical exercise, healthy eating habits, or weight loss; lower blood pressure; or lower blood sugar
  • Not planning to live in local area over the next year
  • Intensive cancer treatment such as bone marrow transplant, chemotherapy, radiation, or cancer related surgery (not including hormonal chemotherapy like Tamoxifen) in last six months or next 12 months
  • Other serious health issues or personal concerns that could prevent participant from completing study

Study Design

Enrollment

500 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: MiWeigh

active comparator: Enhanced Usual Care

Interventions

MiWeigh

Participants will complete a baseline assessment that includes a survey, blood draw, and body measurements. Participants will be given access to a website with information on weight-loss options and have at least one visit with a doctor that has special training in obesity medicine. Prior to this visit, clinical pre-surveys and additional laboratory blood tests will be completed. During this visit, the doctor will work with the participant to develop an individualized weight-loss treatment plan. Additionally, participants will report weight weekly via text and receive periodic supportive messages via the health portal or phone call.

Enhanced Usual Care (EUC)

Participants will complete assessments at baseline and 12 months that include a survey, blood draw, and body measurements, plus a survey at 6 months. Once randomized, participants will be given access to a website with information on weight-loss options and advised to see their primary care provider if a participant wishes to discuss the options.

Primary outcome measure

  • Mean change in body weight in kilograms from baseline to 12 months. [ Time Frame: Baseline to 12 months ]

Central Contacts and Locations

Central contacts

Shelley Stoll

734-232-0697scstoll@med.umich.edu

Locations

University of Michigan

Recruiting

Ann Arbor, Michigan, United States, 48109

Contacts

Shelley Stoll, MPH

734-232-0697scstoll@med.umich.edu

Principal Investigator:

Dina Griauzde, MD, MSc

More Information

Sponsor

University of Michigan

Last update posted

Jun 12, 2026

Last verified

Jun, 2026

Keywords

  • Weight loss program
  • Related Chronic health condition
  • Questionnaires
  • Blood draws

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Michigan on 2026-06-12.